PNET5 Trial | Transforming Treatments for Childhood Brain Tumours
Medulloblastomas are the most common high grade brain tumours in children. The standard treatment for this tumour type is removing the tumour with surgery, followed with chemotherapy and radiotherapy.
However, these treatments are quite aggressive and cause long-term, life-altering disabilities. The PNET5 clinical trial aims to improve the quality of survival of these children by providing kinder and tailored treatments.
Up till now, all children with a medulloblastoma are treated in exactly the same way, even though there are different subtypes of this tumour.
This trial should demonstrate that kinder treatments can be given to those children with lower-risk tumours without risking their survival, but still improving their quality of life.
Find out more about the PNET5 Clinical Trial:
thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-brain-tumour-children/medulloblastoma/medulloblastoma-research/pnet5-trial/
#ACureCantWait
No comments found